Regency Centers (REG) – PRNewswire
-
Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600
-
RemeGen's Telitacicept Demonstrates Positive Results in Phase II Trial in Treatment of Primary Sjögren's Syndrome
-
RemeGen Reiterates Commitment to Its Battle Against Autoimmune Disease on World Strengthened Immunity Day 2021
-
RemeGen's Telitacicept and Disitamab Vedotin Enter China's National Reimbursement Drug List for SLE and Gastric Cancer Treatment
-
Global Metals & Mining Investor Presentations Now Available for On-Demand Viewing
-
Global Metals & Mining Live Virtual Investor Conference October 20th, 21st, 22nd
-
OTC Markets Group Welcomes Regulus Resources Inc. to OTCQX
Back to REG Stock Lookup